Selective Recognition of Oncogene Promoter C-Myc G-Quadruplex: Design, Synthesis, and In Vitro Evaluation of Naphthalimide and Imidazo[1,2- a ]pyrazines for Their Anticancer Activity
ACS Applied Bio Materials · 2025
DOI: 10.1021/acsabm.4c01666 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2025. Verfasst von Palak Sharma und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Thapar Institute of Engineering and Technology, Patiala 147001, India. Hauptthemen laut MEDLINE: Naphthalimides, Antineoplastic Agents, Pyrazines, G-Quadruplexes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Science and Engineering Research Board, CEEMS, TIET.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, Thapar Institute of Engineering and Technology, Patiala 147001, India.
ORCID-Profile: Kamaldeep Paul
Förderung
- Science and Engineering Research Board
- CEEMS, TIET
Zitieren
APA
Sharma, P., & Paul, K. (2025). Selective Recognition of Oncogene Promoter C-Myc G-Quadruplex: Design, Synthesis, and In Vitro Evaluation of Naphthalimide and Imidazo[1,2- a ]pyrazines for Their Anticancer Activity. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.4c01666
Vancouver
Sharma P, Paul K. Selective Recognition of Oncogene Promoter C-Myc G-Quadruplex: Design, Synthesis, and In Vitro Evaluation of Naphthalimide and Imidazo[1,2- a ]pyrazines for Their Anticancer Activity. ACS Applied Bio Materials. 2025. doi:10.1021/acsabm.4c01666
BibTeX
@article{Sharma2025,
author = {Sharma, Palak and Paul, Kamaldeep},
title = {Selective Recognition of Oncogene Promoter C-Myc G-Quadruplex: Design, Synthesis, and In Vitro Evaluation of Naphthalimide and Imidazo[1,2- a ]pyrazines for Their Anticancer Activity},
journal = {ACS Applied Bio Materials},
year = {2025},
doi = {10.1021/acsabm.4c01666}
}
EUVIMED